IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adverum Biotechnologies Inc (ADVMCHF)

CUSIP: 00773U108 | XZ | 380 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ABML Investment Partners, L.P.00.0%Fell below 5%Dec 9, 2025No 13F filer matched
13D/ABML Investment Partners, L.P.0
0.0% of class · Dec 9, 2025Fell below 5%
No 13F filer matched

Institutional Holders — Q3 2025

Versant Venture Management, LLC506,821
1.1% of portfolio›$2.3M
StyleTurnoverLocationFiled
Versant Venture Management, LLC
506,821$2.3M1.1%Deep ValueMediumSan Francisco, CA2025-11-10